Literature DB >> 7974344

Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet.

E M Bladbjerg1, P Marckmann, B Sandström, J Jespersen.   

Abstract

Preliminary observations have suggested that non-fasting factor VII coagulant activity (FVII:C) may be related to the dietary fat content. To confirm this, we performed a randomised cross-over study. Seventeen young volunteers were served 2 controlled isoenergetic diets differing in fat content (20% or 50% of energy). The 2 diets were served on 2 consecutive days. Blood samples were collected at 8.00 h, 16.30 h and 19.30 h, and analysed for triglycerides, FVII coagulant activity using human (FVII:C) or bovine thromboplastin (FVII:Bt), and FVII amidolytic activity (FVII:Am). The ratio FVII:Bt/FVII:Am (a measure of FVII activation) increased from fasting levels on both diets, but most markedly on the high-fat diet. In contrast, FVII:Am (a measure of FVII protein) tended to decrease from fasting levels on both diets. FVII:C rose from fasting levels on the high-fat diet, but not on the low-fat diet. The findings suggest that high-fat diets increase non-fasting FVII:C, and consequently may be associated with increased risk of thrombosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7974344

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

1.  Dietary cocoa butter or refined olive oil does not alter postprandial hsCRP and IL-6 concentrations in healthy women.

Authors:  Tine Tholstrup; Kim-Tiu Teng; Marianne Raff
Journal:  Lipids       Date:  2011-02-02       Impact factor: 1.880

2.  The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials.

Authors:  Penny M Kris-Etherton; Paul W Stewart; Henry N Ginsberg; Russell P Tracy; Michael Lefevre; Patricia J Elmer; Lars Berglund; Abby G Ershow; Thomas A Pearson; Rajasekhar Ramakrishnan; Stephen F Holleran; Barbara H Dennis; Catherine M Champagne; Wahida Karmally
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

3.  Is lipid lowering therapy an independent risk factor for venous thromboembolism? A population-based case-control study.

Authors:  Aneel A Ashrani; Michel K Barsoum; Daniel J Crusan; Tanya M Petterson; Kent R Bailey; John A Heit
Journal:  Thromb Res       Date:  2015-04-11       Impact factor: 3.944

4.  Effects of different protein sources on plasminogen inhibitor-1 and factor VII coagulant activity added to a fat-rich meal in type 2 diabetes.

Authors:  Lene S Mortensen; Claus Thomsen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2010-11-10

Review 5.  Diet and hemostatic factors.

Authors:  R P Tracy
Journal:  Curr Atheroscler Rep       Date:  1999-11       Impact factor: 5.967

6.  The role of dyslipidemia and statins in venous thromboembolism.

Authors:  Joel G Ray; Frits R Rosendaal
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

7.  Proprotein convertase subtilisin/kexin type 9 (PCSK9) Deficiency is Protective Against Venous Thrombosis in Mice.

Authors:  Hui Wang; Qian Wang; Jintao Wang; Chiao Guo; Kyle Kleiman; He Meng; Jason S Knight; Daniel T Eitzman
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.